Nuance Investments adds Varian Medical Systems (VAR) to its portfolio

Varian Medical Systems (VAR) : Nuance Investments added new position in Varian Medical Systems during the most recent quarter end. The investment management firm now holds 53,705 shares of Varian Medical Systems which is valued at $5,083,178 , the company said in a statement filed on Aug 2, 2016 with the SEC.Varian Medical Systems makes up approximately 0.53% of Nuance Investments’s portfolio.

Other Hedge Funds, Including , Tradelink Capital sold out all of its stake in VAR during the most recent quarter. The investment firm sold 2,472 shares of VAR which is valued $233,975.Tnb Financial boosted its stake in VAR in the latest quarter, The investment management firm added 2,701 additional shares and now holds a total of 80,564 shares of Varian Medical Systems which is valued at $7,017,930. Varian Medical Systems makes up approx 1.80% of Tnb Financial’s portfolio.Boys Arnold Co Inc boosted its stake in VAR in the latest quarter, The investment management firm added 485 additional shares and now holds a total of 5,710 shares of Varian Medical Systems which is valued at $493,801. Varian Medical Systems makes up approx 0.08% of Boys Arnold Co Inc’s portfolio.Bnp Paribas Arbitrage Sa boosted its stake in VAR in the latest quarter, The investment management firm added 8,109 additional shares and now holds a total of 33,581 shares of Varian Medical Systems which is valued at $2,854,049. Varian Medical Systems makes up approx 0.01% of Bnp Paribas Arbitrage Sa’s portfolio.

Varian Medical Systems closed down -0.24 points or -0.25% at $95.01 with 4,18,502 shares getting traded on Monday. Post opening the session at $95.25, the shares hit an intraday low of $94.74 and an intraday high of $95.47 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Varian Medical Systems reported $1.22 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $1.17. The company had revenue of $789.40 million for the quarter, compared to analysts expectations of $782.00 million. The company’s revenue was up .7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.15 EPS.

Many Wall Street Analysts have commented on Varian Medical Systems. Company shares were Reiterated by Barrington Research on Jul 28, 2016 to “Outperform”, Firm has raised the Price Target to $ 102 from a previous price target of $93 .

Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy radiosurgery proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical scientific and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer taking X-ray images and protecting ports and borders. The Company’s products include linear accelerators brachytherapy afterloaders treatment simulation and verification equipment accessories information management treatment planning and image processing software. The Company’s customers include university research and community hospitals private and governmental institutions healthcare agencies doctors’ offices and cancer care clinics.

Leave a Reply

Varian Medical Systems - Is it time to Sell?

Top Brokerage Firms are advising their investors on Varian Medical Systems. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.